Skip to main content
Clinical Trials/NCT03517735
NCT03517735
Terminated
Not Applicable

Postoperative Sedation After Cardiac Surgery : Comparison Between Manual Administration and Automated Sedation

CMC Ambroise Paré1 site in 1 country7 target enrollmentDecember 17, 2018

Overview

Phase
Not Applicable
Intervention
Remifentanil
Conditions
Anesthesia
Sponsor
CMC Ambroise Paré
Enrollment
7
Locations
1
Primary Endpoint
Adequate sedation
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

This study compares automated administration of propofol and remifentanil guided by the Bispectral index (BIS) versus manual administration for sedation after cardiac surgery.

Detailed Description

Automated sedation has the potential to improve patient care after cardiac surgery by adjusting drug doses to the minimum required for efficacy. Indeed, automated and continuous titration may avoid overdosing, improve hemodynamic stability and also decrease the mean time to tracheal extubation. Medsteer SAS developed a controller, EasyTiva device, allowing the closed-loop coadministration of propofol and remifentanil, guided by a Bispectral Index (BIS) monitor. Automated sedation is so facilitated by the BIS which permits continuous monitoring of electrocortical activity. This randomized monocentric trial compares the automated administration with manual intravenous administration of propofol-remifentanil for maintaining adequate depth of hypnosis (BIS 55-75) during sedation after cardiac surgery.

Registry
clinicaltrials.gov
Start Date
December 17, 2018
End Date
March 30, 2019
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
CMC Ambroise Paré
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Cardiac surgical procedure requiring postoperative sedation
  • Low operative risk : EuroSCORE 2 ≤ 5%
  • Consent for participation
  • Affiliation to the social security system

Exclusion Criteria

  • Pregnant or breastfeeding women
  • Neurological or muscular disorder
  • Pacemaker
  • Hypersensitivity to propofol or remifentanil
  • Communication difficulties or neuropsychiatric disorder

Arms & Interventions

Manual postoperative sedation

Manual administration of Propofol and Remifentanil.

Intervention: Remifentanil

Automated postoperative sedation

Automated administration of Propofol and Remifentanil.

Intervention: EasyTiva (algorithm is the property of Medsteer SAS)

Automated postoperative sedation

Automated administration of Propofol and Remifentanil.

Intervention: Propofol

Automated postoperative sedation

Automated administration of Propofol and Remifentanil.

Intervention: Remifentanil

Manual postoperative sedation

Manual administration of Propofol and Remifentanil.

Intervention: Propofol

Outcomes

Primary Outcomes

Adequate sedation

Time Frame: 6 hours

Percentage of time with BIS between 55 and 75 (BIS(55-75))

Secondary Outcomes

  • Level of sedation(6 hours)
  • Dose of hypnotic drug(6 hours)
  • Awareness during the sedation period(48 hours)
  • Period of too light sedation(6 hours)
  • Level of pain after extubation(9 hours)
  • Period of too deep sedation(6 hours)
  • Level of pain during sedation(6 hours)
  • Incidence of Burst Suppression (bsr) during sedation(6 hours)
  • Medical interventions(6 hours)
  • Sedation time(6 hours)
  • Delay before awakening(6 hours)
  • Dose of analgesic drug(6 hours)
  • Level of consciousness after extubation(9 hours)
  • Hemodynamic status during the sedation period(6 hours)

Study Sites (1)

Loading locations...

Similar Trials